Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2000 Aug;83(2):176–178. doi: 10.1136/adc.83.2.176

Which children should receive growth hormone treatment

C BROOK 1, C KELNAR 1, P BETTS 1
PMCID: PMC1718444  PMID: 10950748

Full Text

The Full Text of this article is available as a PDF (72.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Busschbach J. J., Rikken B., Grobbee D. E., De Charro F. T., Wit J. M. Quality of life in short adults. Horm Res. 1998;49(1):32–38. doi: 10.1159/000023123. [DOI] [PubMed] [Google Scholar]
  2. Carel J. C., Mathivon L., Gendrel C., Ducret J. P., Chaussain J. L. Near normalization of final height with adapted doses of growth hormone in Turner's syndrome. J Clin Endocrinol Metab. 1998 May;83(5):1462–1466. doi: 10.1210/jcem.83.5.4777. [DOI] [PubMed] [Google Scholar]
  3. Cutfield W. S., Wilton P., Bennmarker H., Albertsson-Wikland K., Chatelain P., Ranke M. B., Price D. A. Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet. 2000 Feb 19;355(9204):610–613. doi: 10.1016/S0140-6736(99)04055-6. [DOI] [PubMed] [Google Scholar]
  4. Darendeliler F., Hindmarsh P. C., Brook C. G. Dose-response curves for treatment with biosynthetic human growth hormone. J Endocrinol. 1990 May;125(2):311–316. doi: 10.1677/joe.0.1250311. [DOI] [PubMed] [Google Scholar]
  5. Dattani M. T., Pringle P. J., Hindmarsh P. C., Brook C. G. What is a normal stimulated growth hormone concentration? J Endocrinol. 1992 Jun;133(3):447–450. doi: 10.1677/joe.0.1330447. [DOI] [PubMed] [Google Scholar]
  6. Donaldson M. D. Growth hormone therapy in Turner syndrome--current uncertainties and future strategies. Horm Res. 1997;48 (Suppl 5):35–44. doi: 10.1159/000191327. [DOI] [PubMed] [Google Scholar]
  7. Downie A. B., Mulligan J., Stratford R. J., Betts P. R., Voss L. D. Are short normal children at a disadvantage? The Wessex growth study. BMJ. 1997 Jan 11;314(7074):97–100. doi: 10.1136/bmj.314.7074.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Guyda H. J. Four decades of growth hormone therapy for short children: what have we achieved? J Clin Endocrinol Metab. 1999 Dec;84(12):4307–4316. doi: 10.1210/jcem.84.12.6189. [DOI] [PubMed] [Google Scholar]
  9. Haverkamp F., Ranke M. B. The ethical dilemma of growth hormone treatment of short stature: a scientific theoretical approach. Horm Res. 1999 Dec;51(6):301–304. doi: 10.1159/000023417. [DOI] [PubMed] [Google Scholar]
  10. Juul A., Bernasconi S., Chatelain P., Hindmarsh P., Hochberg Z., Hokken-Koelega A., de Muinck Keizer-Schrama S. M., Kiess W., Oberfield S., Parks J. Diagnosis of growth hormone (GH) deficiency and the use of GH in children with growth disorders. Horm Res. 1999 Dec;51(6):284–299. doi: 10.1159/000023416. [DOI] [PubMed] [Google Scholar]
  11. Juul A., Bernasconi S., Chatelain P., Hindmarsh P., Hochberg Z., Hokken-Koelega A., de Muinck Keizer-Schrama S. M., Kiess W., Oberfield S., Parks J. Diagnosis of growth hormone (GH) deficiency and the use of GH in children with growth disorders. Horm Res. 1999 Dec;51(6):284–299. doi: 10.1159/000023416. [DOI] [PubMed] [Google Scholar]
  12. Kelnar C. J., Albertsson-Wikland K., Hintz R. L., Ranke M. B., Rosenfeld R. G. Should we treat children with idiopathic short stature? Horm Res. 1999;52(3):150–157. doi: 10.1159/000023452. [DOI] [PubMed] [Google Scholar]
  13. Kelnar C. J. Pride and prejudice--stature in perspective. Acta Paediatr Scand Suppl. 1990;370:5–15. doi: 10.1111/j.1651-2227.1990.tb11662.x. [DOI] [PubMed] [Google Scholar]
  14. Lampit M., Nave T., Hochberg Z. Water and sodium retention during short-term administration of growth hormone to short normal children. Horm Res. 1998;50(2):83–88. doi: 10.1159/000023239. [DOI] [PubMed] [Google Scholar]
  15. Orme S. M., McNally R. J., Cartwright R. A., Belchetz P. E. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab. 1998 Aug;83(8):2730–2734. doi: 10.1210/jcem.83.8.5007. [DOI] [PubMed] [Google Scholar]
  16. Ranke M. B., Lindberg A., Chatelain P., Wilton P., Cutfield W., Albertsson-Wikland K., Price D. A. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study. J Clin Endocrinol Metab. 1999 Apr;84(4):1174–1183. doi: 10.1210/jcem.84.4.5634. [DOI] [PubMed] [Google Scholar]
  17. Rekers-Mombarg L. T., Busschbach J. J., Massa G. G., Dicke J., Wit J. M. Quality of life of young adults with idiopathic short stature: effect of growth hormone treatment. Dutch Growth Hormone Working Group. Acta Paediatr. 1998 Aug;87(8):865–870. doi: 10.1080/080352598750013653. [DOI] [PubMed] [Google Scholar]
  18. Ritzén E. M., Czernichow P., Preece M., Ranke M., Wit J. M. Safety of human growth hormone therapy. Horm Res. 1993;39(3-4):92–94. doi: 10.1159/000182702. [DOI] [PubMed] [Google Scholar]
  19. Saggese G., Ranke M. B., Saenger P., Rosenfeld R. G., Tanaka T., Chaussain J. L., Savage M. O. Diagnosis and treatment of growth hormone deficiency in children and adolescents: towards a consensus. Ten years after the Availability of Recombinant Human Growth Hormone Workshop held in Pisa, Italy, 27-28 March 1998. Horm Res. 1998;50(6):320–340. doi: 10.1159/000023298. [DOI] [PubMed] [Google Scholar]
  20. Sandberg D. E., Brook A. E., Campos S. P. Short stature: a psychosocial burden requiring growth hormone therapy? Pediatrics. 1994 Dec;94(6 Pt 1):832–840. [PubMed] [Google Scholar]
  21. Sas T. C., de Muinck Keizer-Schrama S. M., Stijnen T., Jansen M., Otten B. J., Hoorweg-Nijman J. J., Vulsma T., Massa G. G., Rouwe C. W., Reeser H. M. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial. J Clin Endocrinol Metab. 1999 Dec;84(12):4607–4612. doi: 10.1210/jcem.84.12.6241. [DOI] [PubMed] [Google Scholar]
  22. Taback S. P., Guyda H. J., Van Vliet G. Pharmacological manipulation of height: qualitative review of study populations and designs. Clin Invest Med. 1999 Apr;22(2):53–59. [PubMed] [Google Scholar]
  23. Tanner J. M., Whitehouse R. H., Hughes P. C., Vince F. P. Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome, and other complaints. Arch Dis Child. 1971 Dec;46(250):745–782. doi: 10.1136/adc.46.250.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Voss L. D. Short but normal. Arch Dis Child. 1999 Oct;81(4):370–371. doi: 10.1136/adc.81.4.370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Zimet G. D., Owens R., Dahms W., Cutler M., Litvene M., Cuttler L. Psychosocial outcome of children evaluated for short stature. Arch Pediatr Adolesc Med. 1997 Oct;151(10):1017–1023. doi: 10.1001/archpedi.1997.02170470051010. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES